Objectives The aim of this study was to assess the impact of a multi-component program, including partially hydrolyzed guar gum (PHGG, Sunfiber®) supplementation, on glycemic control, gut health, and nutritional status to support diabetes prevention and management among Korean adults.
Methods A single-arm trial was conducted with 29 adults (aged 20-55 years) with fasting plasma glucose (FPG) ≥ 100 mg/dL. Over a six-week period, participants engaged in a multi-component program that incorporated the supplementation of PHGG (Sunfiber®, 12.5 g/day), weekly nutritional coaching, and the use of continuous glucose monitoring devices. The program’s effectiveness was evaluated by measuring FPG and glycated hemoglobin (HbA1c) levels through blood tests conducted before and after the intervention. Improvements in gut health were gauged using the Korean Gut Quotient Measurement Scales, while enhancements in nutritional status were assessed using the Nutrition Quotient (NQ) and surveys that evaluated improvements in gut health and nutritional status.
Results Participants’ average age was 43.89 years, with approximately 80% being male. Most participants (about 75%) were classified as overweight or obese. After six-weeks, 17 participants who adhered closely to the program (meeting certification criteria) exhibited significant reductions in key blood glucose markers. FPG levels decreased from 113.06 ± 23.16 mg/dL to 106.24 ± 16.33 mg/dL (P < 0.05), and HbA1c levels decreased from 6.08% ± 0.81% to 5.87% ± 0.53% (P < 0.05). The NQ evaluation revealed significant increases in comprehensive nutrition scores, and in the balance and practice domain scores for all participants (P < 0.05). Furthermore, in the gut health survey, approximately 82.1% of all participants reported experiencing positive changes.
Conclusion Among adults with elevated FPG levels, a multi-component intervention program that included PHGG (Sunfiber®) supplementation, structured dietary management, and the use of health-monitoring devices showed significant benefits in improving glycemic control, overall nutritional status, and gut health.
Trial Registration: Clinical Research Information Service Identifier: KCT0010049.